TRIM63 and cancer: MuRF-1/Trim63 and Atrogin1/Fbxo32 are well-known E3 ligases that are upregulated in conditions that lead to muscle wasting, such as those seen in chemotherapy, cancer cachexia, glucocorticoid treatment, and muscle disuse (9, 31).